The results for the quarter ended June 30, 2013 are as follows:
- Net revenue was $57.7 million, a 12.1% increase from $51.5 million in the first quarter of 2013 and a 1.5% decrease from $58.6 million in the second quarter of 2012.
- Gross margin was 53.6%, compared with 53.2% in the first quarter of 2013 and 53.2% in the second quarter of 2012.
- GAAP operating expenses were $26.0 million, including $26.3 million for research and development (R&D) and selling, general and administrative (SG&A) expenses, which included $5.0 million for stock-based compensation, and $(0.3) million for litigation benefit. Comparatively, for the quarter ended June 30, 2012, GAAP operating expenses were $24.4 million, including $24.6 million for R&D and SG&A expenses, which included $3.7 million for stock-based compensation, and $(0.2) million for litigation benefit.
- Non-GAAP(1) operating expenses were $21.0 million, excluding $5.0 million for stock-based compensation, compared with $20.7 million, excluding $3.7 million for stock-based compensation, for the quarter ended June 30, 2012.
- GAAP net income was $5.5 million and GAAP earnings per share were $0.14 per diluted share. Comparatively, GAAP net income was $6.6 million and GAAP earnings per share were $0.18 per diluted share for the quarter ended June 30, 2012.
- Non-GAAP(1) net income was $9.3 million and non-GAAP earnings per share were $0.24 per diluted share, excluding stock-based compensation and a one-time cash award and related tax effects, compared with non-GAAP net income of $10.1 million and non-GAAP earnings per share of $0.28 per diluted share, excluding stock-based compensation and related tax effects, for the quarter ended June 30, 2012.
The results for the six months ended June 30, 2013 are as follows:
- Net revenue was $109.2 million, a 0.1% increase from $109.1 million for the six months ended June 30, 2012.
- Gross margin was 53.4%, compared with 52.8% for the six months ended June 30, 2012.
- GAAP operating expenses were $51.1 million, including $51.7 million for R&D and SG&A expenses, which included $9.5 million for stock-based compensation, and $(0.6) million for litigation benefit. Comparatively, for the six months ended June 30, 2012, GAAP operating expenses were $47.6 million, including $47.7 million for R&D and SG&A expenses, which included $6.9 million for stock-based compensation, and $(0.1) million for litigation benefit.
- Non-GAAP(1) operating expenses were $41.5 million, excluding $9.5 million for stock-based compensation, compared with $40.7 million, excluding $6.9 million for stock-based compensation, for the six months ended June 30, 2012.
- GAAP net income was $8.0 million and GAAP earnings per share were $0.21 per diluted share. Comparatively, GAAP net income was $9.6 million and GAAP earnings per share were $0.27 per diluted share for the six months ended June 30, 2012.
- Non-GAAP(1) net income was $15.7 million and non-GAAP earnings per share were $0.41 per diluted share, excluding stock-based compensation and a one-time cash award and related tax effects, compared with non-GAAP net income of $16.3 million and non-GAAP earnings per share of $0.46 per diluted share, excluding stock-based compensation and related tax effects, for the six months ended June 30, 2012.
The following is a summary of revenue by end market for the periods indicated, estimated based on the Company's assessment of available end market data (in millions):
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, |
|
Six months ended June 30, | ||||
End Market |
|
2013 |
|
2012 |
|
2013 |
|
2012 |
Communication |
|
$ 14.9 |
|
$ 14.1 |
|
$ 28.2 |
|
$ 25.9 |
Storage and Computing |
|
10.9 |
|
10.4 |
|
23.1 |
|
20.4 |
Consumer |
|
23.9 |
|
26.2 |
|
42.7 |
|
50.1 |
Industrial |
|
8.0 |
|
7.9 |
|
15.2 |
|
12.7 |
Total |
|
$ 57.7 |
|
$ 58.6 |
|
$ 109.2 |
|
$ 109.1 |